Understanding Your Medical Lab Test: What It Is, How It Is Performed, and What the Results Mean
This test measures IgA antibodies against Borrelia burgdorferi, the bacterium that causes Lyme disease, to help diagnose recent or ongoing infection.
{"Detects IgA antibodies to Borrelia burgdorferi bacteria","Used to support Lyme disease diagnosis, often alongside IgG and IgM tests","Positive results indicate current or past exposure to Lyme disease bacteria","Testing is typically done using ELISA followed by Western blot confirmation","Early detection and treatment with antibiotics is important for recovery"}
Key facts at a glance
- LOINC
- 53362-0
- Short code
- B49AA
- Synonyms
- B burgdor 49736 IgA Ser-aCnc
- Category
- chemistry
- Sample
- serum
- Container
- Serum separator tube (SST)
- Units
- N/A
- Fasting
- false
- Population
- adult
- Sex
- all
- Age range
- 18–65 years
- Method
- Immunoblot (Western Blot)
- CPT
- 86617
- SNOMED
- 416586003
- Specimen volume
- 1 mL serum
- Stability
- Stable for 7 days at 2-8°C; stable for longer periods at -20°C or below
- Hemolysis max
- 500
- Lipemia max
- 1000
- Icterus max
- 500
- TAT
- 48–168 hours
- Order
- routine
This test is a laboratory procedure that measures specific substances in a sample of your blood, urine, or other body tissue. Your doctor may order it as part of a routine checkup, to help diagnose a medical condition, to investigate symptoms, or to monitor how well an ongoing treatment is working.
The Borrelia burgdorferi IgA Antibody test is a blood test that detects IgA antibodies against the bacteria Borrelia burgdorferi, which causes Lyme disease. IgA antibodies are one of the first types of antibodies the immune system produces in response to infection. This test is typically ordered when a patient has symptoms suggestive of Lyme disease, such as the characteristic bull's-eye rash (erythema migrans), fever, headache, fatigue, or joint pain, especially after a tick bite or exposure to tick-infested areas.
The test is usually performed in two stages: first, an ELISA (enzyme-linked immunosorbent assay) screening test is done, and if positive or indeterminate, it is followed by a Western blot test for confirmation. Testing for IgA antibodies is often done alongside IgG and IgM antibody tests to provide a more complete picture of the infection timeline.
The test is usually performed by a trained healthcare professional who collects a small sample, most often through a blood draw from a vein in your arm. The procedure takes only a few minutes, and you may feel a brief pinch at the needle site. The sample is then sent to a laboratory, where trained technicians analyze it and forward the results to your doctor.
A healthcare professional will draw a blood sample from a vein in your arm. The blood sample is then sent to a laboratory where it is analyzed for the presence of IgA antibodies specific to Borrelia burgdorferi. No special preparation is typically required before the test, though it's important to inform your healthcare provider about any recent infections, medications, or immune conditions that might affect the test results.
Your results will show whether the measured values fall within the normal reference range for this test. Values that are higher or lower than normal may point to an infection, inflammation, organ dysfunction, or another condition that requires follow-up. Your doctor will interpret the numbers together with your symptoms, medical history, and other test findings, so always discuss the report with your healthcare provider before drawing any conclusions.
Results are typically reported as positive, negative, or equivocal (indeterminate). A positive or indeterminate result suggests that IgA antibodies to Borrelia burgdorferi have been detected, indicating exposure to the bacteria. However, false positives can occur due to cross-reactivity with other conditions. A negative result does not completely rule out Lyme disease, especially in early stages when antibodies may not have developed yet. The interpretation of results should always be done by your healthcare provider in the context of your symptoms, exposure history, and other test results.
Reference range
NegativeN/A
No special patient preparation required.
Clinical interpretation
How abnormal results are interpreted and what conditions they suggest.
The IgA antibody test for Borrelia burgdorferi is primarily used as part of the diagnostic workup for Lyme disease. It can help confirm infection when patients present with symptoms consistent with early or disseminated Lyme disease. However, it is important to note that no single test is definitive, and diagnosis is based on a combination of clinical symptoms, exposure history, and laboratory findings. Early detection is crucial as prompt antibiotic treatment can prevent complications such as neurological problems, joint inflammation, and cardiac issues. The IgA test may be particularly useful in detecting early infection, as IgA antibodies often appear before IgG antibodies in some infections.
Frequently asked questions
Why is IgA testing done along with IgG and IgM tests?
Can I have Lyme disease if the test is negative?
Do I need to fast before this test?
How long does it take to get results?
What should I do if my test is positive?
Sources
- 1
- 2
- 3
- 4
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy